Intra-Cellular Therapies Secures $70,308,475 New Financing

  • Feed Type
  • Date
  • Company Name
    Intra-Cellular Therapies
  • Mailing Address
    3960 Broadway New York, NY 10032
  • Company Description
    Intra-Cellular Therapies (ITI) is developing novel drugs for the treatment of neuropsychiatric and neurologic diseases and other disorders of the Central Nervous System (CNS).
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing. Not a solicitation.
  • M&A Terms
  • Venture Investor

Trending on Xconomy